Bronchiolitis: Two French studies demonstrate the effectiveness of nirsevimab to protect infants
After a 2022–2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French ...
May 28, 2024
0
0